These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 37183664

  • 21. Transcriptional induction of NF-κB-inducing kinase by E2F4/5 facilitates collective invasion of GBM cells.
    Pflug KM, Lee DW, McFadden K, Herrera L, Sitcheran R.
    Sci Rep; 2023 Aug 11; 13(1):13093. PubMed ID: 37567906
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. The noncanonical NF-κB pathway.
    Sun SC.
    Immunol Rev; 2012 Mar 11; 246(1):125-40. PubMed ID: 22435551
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Design, Synthesis, and Biological Evaluation of a Novel NIK Inhibitor with Anti-Inflammatory and Hepatoprotective Effects for Sepsis Treatment.
    Zhang N, Shen S, Yang M, He S, Liu C, Li H, Lu T, Liu H, Hu Q, Tang W, Chen Y.
    J Med Chem; 2024 Apr 11; 67(7):5617-5641. PubMed ID: 38563549
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. The kinase NIK as a therapeutic target in multiple myeloma.
    Gardam S, Beyaert R.
    Expert Opin Ther Targets; 2011 Feb 11; 15(2):207-18. PubMed ID: 21204728
    [Abstract] [Full Text] [Related]

  • 29. TNAP, a novel repressor of NF-kappaB-inducing kinase, suppresses NF-kappaB activation.
    Hu WH, Mo XM, Walters WM, Brambilla R, Bethea JR.
    J Biol Chem; 2004 Aug 20; 279(34):35975-83. PubMed ID: 15208311
    [Abstract] [Full Text] [Related]

  • 30. B-cell CLL/lymphoma 10 (BCL10) is required for NF-kappaB production by both canonical and noncanonical pathways and for NF-kappaB-inducing kinase (NIK) phosphorylation.
    Bhattacharyya S, Borthakur A, Tyagi S, Gill R, Chen ML, Dudeja PK, Tobacman JK.
    J Biol Chem; 2010 Jan 01; 285(1):522-30. PubMed ID: 19897484
    [Abstract] [Full Text] [Related]

  • 31. Overexpression of NF-κB inducing kinase underlies constitutive NF-κB activation in lung cancer cells.
    Saitoh Y, Martínez Bruyn VJ, Uota S, Hasegawa A, Yamamoto N, Imoto I, Inazawa J, Yamaoka S.
    Lung Cancer; 2010 Dec 01; 70(3):263-70. PubMed ID: 20338663
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Negative regulation of the nuclear factor kappa B-inducing kinase by a cis-acting domain.
    Xiao G, Sun SC.
    J Biol Chem; 2000 Jul 14; 275(28):21081-5. PubMed ID: 10887201
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Interferon induces NF-kappa B-inducing kinase/tumor necrosis factor receptor-associated factor-dependent NF-kappa B activation to promote cell survival.
    Yang CH, Murti A, Pfeffer LM.
    J Biol Chem; 2005 Sep 09; 280(36):31530-6. PubMed ID: 16009713
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. NF-κB inducing kinase: a key regulator in the immune system and in cancer.
    Thu YM, Richmond A.
    Cytokine Growth Factor Rev; 2010 Aug 09; 21(4):213-26. PubMed ID: 20685151
    [Abstract] [Full Text] [Related]

  • 39. Noncanonical NF-κB signaling and the essential kinase NIK modulate crucial features associated with eosinophilic esophagitis pathogenesis.
    Eden K, Rothschild DE, McDaniel DK, Heid B, Allen IC.
    Dis Model Mech; 2017 Dec 19; 10(12):1517-1527. PubMed ID: 29259025
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.